Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Klinische Padiatrie|September 1, 1995
[The microagglutination test--a simple and sensitive procedure for serodiagnosis of pertussis infections]U Heininger, K Stehr, S Schmitt-Grohe, et al.
European Journal of Pediatrics|July 1, 1996
Bordetella pertussis infections and sudden unexpected deaths in childrenU Heininger, K Stehr, G Schmidt-Schläpfer, et al.
The Pediatric Infectious Disease Journal|December 6, 2001
Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativityU Heininger, C Braun-Fahrländer, D Desgrandchamps, et al.
The Journal of Hospital Infection|November 9, 2011
Hospital-associated infections in children: a prospective post-discharge follow-up survey in three different paediatric hospitalsS Kinnula, M Buettcher, T Tapiainen, et al.
Vaccine|May 20, 2004
Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infantsF Zepp, M Knuf, U Heininger, et al.
Infection|July 8, 2000
Optimal tobramycin dosage in patients with cystic fibrosis--evidence for predictability based on previous drug monitoringK Bartel, T Habash, S Lugauer, et al.
Infection and Immunity|October 1, 1996
Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussisS Z Hausman, J D Cherry, U Heininger, et al.
Developments in Biological Standardization|January 1, 1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupM A Uberall, K Stehr, J D Cherry, et al.
Vaccine|December 27, 2011
The concept of vaccination failureU Heininger, N S Bachtiar, P Bahri, et al.
Developments in Biological Standardization|January 1, 1997
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study GroupS Schmitt-Grohé, K Stehr, J D Cherry, et al.
Pageof 9